Company Overview of PreCision Dermatology, Inc.
PreCision Dermatology, Inc., along with its subsidiaries, develops, manufactures, and markets dermatology products. It offers pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company also provides therapeutic and cosmetic skincare solutions. It serves dermatology and skincare markets. PreCision Dermatology, Inc. was incorporated in 2010 and is based in Cumberland, Rhode Island. As of July 7, 2014, PreCision Dermatology, Inc. operates as a subsidiary of Valeant Pharmaceuticals International, Inc.
900 Highland Corporate Drive
Cumberland, RI 02864
Founded in 2010
Key Executives for PreCision Dermatology, Inc.
Chief Executive Officer, Director and President of Onset Dermatologics, Llc
Founder and Senior Advisor
Senior Vice President of Sales and Marketing-Onset Dermatologics
Senior Vice President of Research, Development and Technical Operations
Compensation as of Fiscal Year 2015.
PreCision Dermatology, Inc. Key Developments
Glenmark Generics Inc. Files Lawsuit Against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs
Oct 10 13
Glenmark Generics Inc. has filed a lawsuit in the court of chancery of the state of Delaware against Astellas Pharma Europe B.V, Astellas International, Triax Pharmaceuticals, LLC, Precision Dermatology, Inc, Onset Dermatologics, LLC and Metacon Labs. The lawsuit seeks to enforce Glenmark's exclusive royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV. Under that agreement, Glenmark is entitled to 180 days of exclusivity with respect to its Hydrocortisone Butyrate Cream, as it is the first generic company to file an abbreviated new drug application (ANDA) for the product.
Precision Dermatology Appoints Robert J. Moccia as Chief Executive Officer
Sep 24 13
Precision Dermatology Inc. announced that Robert J. Moccia has been appointed to the position of Chief Executive Officer. He most recently served as COO of Precision and President of Onset Dermatologics Inc.
Golub Capital Provides One-Loan Debt Facility to Support Refinancing of PreCision Dermatology, Inc
Sep 23 13
Golub Capital announced that as Sole Bookrunner and Administrative Agent it provided a $67 million GOLD financing to support the refinancing of PreCision Dermatology, Inc., backed by a syndicate of private equity sponsors including Essex Woodlands Health Ventures, Frazier Healthcare Ventures, Longitude Capital Partners, Boston Millennia Partners, Novaquest Capital Management, and Quaker Bioventures. GOLD financings are Golub Capital's One-Loan Debt facilities.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|